Like most websites, we use cookies and other similar technologies for a number of reasons, such as keeping our website reliable and secure, personalizing content, providing social media features and to better understand how our site is used. By using our site, you are agreeing to our use of these tools. Please review our Privacy Policy to learn more. 

Skip to Content

Don’t put off the essential care you need because of COVID-19. We continue to safely schedule office appointments, surgeries and procedures so you can get the care you need now. We can even help you find a doctor.

the beat

The Beat:
A Bryan Heart Blog

The Beat is a monthly blog from Bryan Heart cardiologists to keep you informed on trending topics, advancements and news in heart care.

Subscribe to receive The Beat to your inbox monthly.

Bryan Heart

To refer a patient to a Bryan Heart cardiologist or surgeon, call 402-483-3333.

Learn about Bryan Heart

How Long do I Have to Take my Stent Medication?

New guidelines for duration of dual antiplatelet therapy in coronary artery disease patients

Written by Bryan Heart cardiologist John Steuter, MD

Patients receive cardiac stents to restore coronary blood flow, alleviate chest pain, and treat a heart attack. After stenting, patients receive dual antiplatelet therapy (DAPT). Since platelets are involved in the clotting process, patients must take dual antiplatelet therapy, which is a combination of Aspirin plus either Plavix, Brilinta or Prasugrel.

The duration of DAPT for patients who receive cardiac stents has been a topic of much debate for some time now. The timing of surgery (noncardiac or cardiac) for a patient was often affected and altered by this duration as these medications would need be held for bleeding risk.

Current Guidelines

The American College of Cardiology (ACC) and American Heart Association (AHA) guidelines recommended stable ischemic heart disease patients continue DAPT for:

  • One year after placement of drug eluting stent
  • Three months after bare metal stent

New Guidelines

On March 29, 2016 the ACC/AHA release new updated guidelines about the duration of DAPT.

Stable ischemic heart disease patients continue DAPT for:

  • Six months, at least, after placement of drug eluting stent
  • One month, at least, after bare mental stent

Additional Guidelines for Continuation of DAPT
Acute coronary syndrome patients (NSTEMI and STMI)

  • Remains one year
  • This also applies specifically to duration of P2Y12 inhibitor therapy (i.e., Plavix, Prasugrel and Brilinta)
  • Aspirin – continue indefinitely

For more information on DAPT guidelines and information, or to refer a patient to a Bryan Heart cardiologist or surgeon, please call 402-483-3333.

steuter john

About John Steuter, MD

John Steuter, MD, is a cardiologist at Bryan Heart. Steuter is a graduate of The University of Nebraska Medical Center College of Medicine and joined Bryan Heart in 2015 after completing his residency and fellowship at The University of Nebraska Medical Center. He is certified with the American Board of Internal Medicine.

View Dr. Steuter’s physician profile


Copyright 2020 Bryan Health. All rights reserved.